Physician profile
Abelardo Deanda
NPI 1437239092
$1,958.47
in general payments reported to CMS, 2019-2025
9 companies · $22.01 in 2025
The $22.01 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $21.07 · 2021: $1,568 · 2024: $223 · 2025: $22.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,430.00 | 2021 | |
| Hemosonics LLC | $110.02 | 2021-2024 | Qunatra Qplus System, Quantra Qplus System |
| Edwards Lifesciences Corporation | $93.81 | 2021 | |
| Boston Scientific Corporation | $83.24 | 2019 | |
| Surmodics, INC. | $77.99 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Solventum Corporation | $55.23 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Abbott Laboratories | $51.05 | 2019-2021 | |
| Abiomed | $35.12 | 2019-2020 | |
| Atricure, INC. | $22.01 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abelardo Deanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.